InsiderDB

Lobbying disclosures · Lobbying report

INCY: second_quarter 2026 lobbying report

Issues relating to CMS coverage and reimbursement policies.

Follow INCY
Became public
Jul 16, 2026, 3:58 PM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 11:48 PM EST

Why this is connected

Legal-name match: INCYTE CORPORATION is INCYTE CORP (https://www.sec.gov/Archives/edgar/data/879169/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported lobbying amounts

Income: $110,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/a0532f09-67eb-4b3c-bf55-36032a8cae92/","filing_uuid":"a0532f09-67eb-4b3c-bf55-36032a8cae92","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/a0532f09-67eb-4b3c-bf55-36032a8cae92/print/","filing_document_content_type":"text/html","income":"110000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kendall Conger","dt_posted":"2026-07-16T15:58:33-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"121 Reynolda Village Way Ste. A","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Winston Salem","registrant_state":"NC","registrant_zip":"27106","registrant":{"id":401109039,"url":"https://lda.gov/api/v1/registrants/401109039/","house_registrant_id":56739,"name":"CHECKMATE GOVERNMENT RELATIONS","description":null,"address_1":"121 Reynolda Village Way Ste. A","address_2":null,"address_3":null,"address_4":null,"city":"Winston Salem","state":"NC","state_display":"North Carolina","zip":"27106","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KENDALL CONGER","contact_telephone":"+1 919-740-1863","dt_updated":"2026-10-13T06:24:23.250297-04:00"},"client":{"id":70274,"url":"https://lda.gov/api/v1/clients/70274/","client_id":70274,"name":"INCYTE CORPORATION","general_description":"Biopharmaceutical Company","client_government_entity":null,"client_self_select":false,"state":"DE","state_display":"Delaware","country":"US","country_display":"United States of America","ppb_state":"DE","ppb_state_display":"Delaware","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-11-11"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues relating to CMS coverage and reimbursement policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148771,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"MCDOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149198,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"KOURY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153373,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":"LUCAS","last_name":"BLANCHAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149175,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"LACIVITA","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in INCY

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.